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Abstract
Regucalcin (RGN) is a mammalian Ca2+-binding protein that plays an important role
in intracellular Ca2+ homeostasis. Recently, RGN has been identified as a target
gene for sex steroid hormones in the prostate glands and testis of rats and humans,
but no studies have focused on RGN expression in bovine tissues. Thus, in the
present study, we examined RGN mRNA and protein expression in the different
tissues and organs of veal calves and beef cattle. Moreover, we investigated
whether RGN expression is controlled through sex steroid hormones in bovine
target tissues, namely the bulbo-urethral and prostate glands and the testis. Sex
steroid hormones are still illegally used in bovine husbandry to increase muscle
mass. The screening of the regulation and function of anabolic sex steroids via
modified gene expression levels in various tissues represents a new approach for
the detection of illicit drug treatments. Herein, we used quantitative PCR, western
blot and immunohistochemistry analyses to demonstrate RGN mRNA and protein
expression in bovine tissues. In addition, estrogen administration down-regulated
RGN gene expression in the accessory sex glands of veal calves and beef cattle,
while androgen treatment reduced RGN gene expression only in the testis. The
confirmation of the regulation of RGN gene expression through sex steroid
hormones might facilitate the potential detection of hormone abuse in bovine
husbandry. Particularly, the specific response in the testis suggests that this tissue
is ideal for the detection of illicit androgen administration in veal calves and beef
cattle.
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Introduction
Regucalcin (RGN) was first identified in 1978 as a calcium (Ca2+)-binding protein
[1], which does not contain the typical EF-hand Ca2+-binding motif [2].
Subsequently, RGN was identified as senescence marker protein-30 (SMP-30)
based on the characteristic down-regulation of this protein with ageing in the rat
liver [3]. As the name suggests, RGN regulates intracellular Ca2+ homeostasis
through the modulation of the activity of Ca2+ channels, Ca2+-ATPase in the
membrane of mitochondria and endoplasmic reticulum [4, 5] and (Ca2+-Mg2+)-
ATPase in the plasma membrane [6, 7]. Moreover, RGN plays an important role
in the regulation of Ca2+-dependent enzymes, such as protein kinases, tyrosine
kinases, phosphatases, phosphodiesterase, nitric oxide synthase and proteases [8–
13].
Several studies have showed a role for RGN in the regulation of cell death and
proliferation; indeed, RGN also regulates DNA synthesis and fragmentation [14–
17] and modulates the expression of oncogenes, tumour suppressor genes and cell
cycle regulators [16–18], influencing cell survival and apoptosis [19–21].
RGN has been localised to the nucleus, cytoplasm [22–23] and the
mitochondria [24]. RGN is widely expressed in a variety of tissues and cell lines
[25–27] and was first identified in the liver, where this protein is highly expressed
[1]. However, RGN mRNA and/or protein expression has also been detected in
the male and female reproductive tract [23, 28–29], submandibular glands [30],
several brain districts [13, 31–32], the heart [33–34], skeletal muscle [35], lung
[36], kidney [35, 37], adrenal glands [19], bone [38–39]. RGN protein has been
also shown to be secreted to biological fluids, namely plasma [31, 40–41] and
seminiferous tubules fluid [29].
The expression of RGN is regulated through many factors, including
intracellular Ca2+ concentration and regulatory transcription factors, namely
transcription factor AP-1 [42], b-catenin [43], nuclear factor I-A1 (NF1-A1) [44]
and RGN gene promoter region-related protein (RGPR-p117) [45–46]. In
addition, Ca2+-independent mechanisms [47], including hormonal factors, such
as thyroid, parathyroid and sex steroid hormones, have been described in the
regulation of RGN expression in cells [23, 28, 48–49, 29]. The regulation of RGN
expression through sex steroids in the rat liver [50], kidney [51] and more
recently, the breast, prostate gland and testis [23, 29] has also been demonstrated.
Monitoring gene regulation via mRNA levels to detect anabolic sex steroid
administration in bovine husbandry is a novel approach for the detection of the
illicit treatment of livestock in meat production. The development of novel
methods [52–56] to facilitate the indirect detection of the illegal administration of
sex steroid hormones and other growth promoters would enhance the efficiency
and success rate of food screening and safety programmes established by state
authorities. Particularly, the transcriptomic approach could facilitate the
identification of biomarkers suitable for the detection of illegally treated animals.
Recent studies have shown that progesterone receptor (PR) gene expression levels
were increased in the bulbo-urethral and prostate glands of 17b-estradiol-treated
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calves and beef cattle [53, 57]. For potential use in food safety monitoring, a
quantitative PCR (qPCR) method has been developed for the detection of up-
regulated PR gene expression in the bulbo-urethral glands of beef cattle and veal
calves illegally administered 17b-estradiol [58].
Currently, there are no studies focusing on RGN expression in bovine tissues
and organs. The first aim of the present study was to investigate RGN gene and
protein expression in different tissues of veal calves and beef cattle. We also
determined whether RGN expression is controlled through sex steroid hormones
in bovine target tissues, namely the bulbo-urethral and prostate glands and the
testis.
The significant change in RGN gene expression may well be an intriguing
biomarker to discover hormone abuse in bovine husbandry. The described
methodology, using an indirect marker to detect illegal hormone treatment,
promises to significantly improve food safety control programs once introduced.
Materials and Methods
Animals
In trial 1, 18 Friesian male veal calves at 4 months of age were used. The calves
were housed in 10615 m boxes with concrete floors lacking litter or lateral
partitions. The calves were tethered and fed with liquid milk replacer twice a day
(providing per kg: 950 g dry matter (DM), 230 g crude protein (CP), 210 g ether
extract (EE), 60 g ash, 1 g cellulose, 75 mg retinol, 50 mg ascorbic acid, 5 mg Cu,
0.125 mg cholecalciferol and 80 mg a-tocopherol). The amount of feed was
gradually increased to 8 L/calf/day and then gradually increased to 16 L/calf/day.
After one month, 0.5 kg of barley straw (per kg: 900 g DM, 20 g CP, 10 g EE, 60 g
ash and 410 g crude fibre) was added to the diet, according to the
recommendations of the European Commission (97/182/EC). The calves were
randomly assigned to 3 experimental groups: group A (n56) received the weekly
intramuscular administration of 17b-estradiol (dissolved in a preparation of ethyl
oleate containing 10% of benzyl alcohol, added as bacteriostatic preservative) 6
times until 1 week before slaughter, for a total of 190 mg/animal; group B (n56)
received the weekly intramuscular administration of testosterone propionate
(diluted in sesame oil) 6 times until 1 week before slaughter, for a total of 1.050
g/animal; group K1 (n56) served as control. The first administration was carried
out approximately at 140 days of age and the entire treatment phase lasted 44
days. The calves were slaughtered at 6 days after the last treatment.
In trial 2, 24 Friesian male beef cattle (7–15 months-old) were bought from
local breeders and allowed to acclimatize for 2 months. The animals were housed
in 10615 m boxes with concrete floors lacking litter or lateral partitions. All
animals were fed a concentrated diet comprising corn silage, corn, hay, and a
commercial protein supplement; water was supplied ad libitum. The beef cattle
were randomly assigned to 3 experimental groups at approximately 10–18
months-old: group C (n58) was administered 200 mg of trenbolone acetate and
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20 mg of 17b-estradiol (Revalor-200, Intervet, USA) through slow-release
subcutaneous pellets for 89 days; group D (n58) was administered 200 mg of
trenbolone acetate (Finaplix-H, Intervet) through slow-release subcutaneous
pellets for 89 days; group K2 (n58) served as control. The implants remained in
place until slaughter.
The hormone dosages in both trials were selected according to previous studies
[57, 59–62].
The animals in trials 1 and 2 were healthy upon intra vitam and post mortem
examinations.
The experiments were authorised through the Italian Ministry of Health and
the Ethical Committee of the University of Turin. The carcasses of the treated
animals were appropriately destroyed (2003/74/CE – DL 16 March 2006,
No. 158).
Tissue sampling and processing
Parenchymal samples of the liver, kidney cortex, perirenal fat, adrenal cortex,
adrenal medulla, lung, heart, skeletal muscle, cervical thymus, thoracic thymus,
pituitary gland, salivary gland, bulbo-urethral gland, prostate and testis tissues
were obtained from each animal. The sampling was carried out with the same
procedure, immediately after the slaughter, for all animals. Samples were
immediately frozen in liquid nitrogen and then stored at 280 C˚ for molecular and
western blot (WB) analyses. Samples from bulbo-urethral glands, prostate and
testis of calves of trial 1 were also fixed in 10% neutral buffered formalin at room
temperature and paraffin-embedded for immunohistochemistry (IHC).
Chemicals
All chemicals, unless otherwise stated, were purchased from Sigma (St. Louis, MO,
USA).
RNA extraction, reverse transcription and PCR
RGN mRNA expression was analysed in the tissues of calves and beef cattle using
polymerase chain reaction (PCR). Several milligrams of each tissue sample were
disrupted using a TissueLyser II (Qiagen, Hilden, Germany) using stainless steel
beads in 1 mL of TRIzol Reagent (Ambion, Life Technologies, Carlsbad, CA,
USA) according to the manufacturer’s protocol. The RNA concentration was
spectrophotometrically determined, and the RNA integrity was evaluated using an
automated electrophoresis station (Experion Instrument, Bio-Rad, Hercules, CA,
USA). cDNA was synthesised from 1 mg of total RNA using the QuantiTect
Reverse Transcription Kit (Qiagen).
The cDNA was subjected to PCR using Taq DNA Polymerase (Qiagen) and the
following PCR protocol: initial denaturation (94 C˚ for 3 min), followed by 35
amplification cycles (94 C˚ for 1 min, 60 C˚ for 1 min, 72 C˚ for 1 min) and a final
extension (72 C˚ for 10 min). The primer sequences for RGN were designed using
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Primer3 software (vers. 4.0.0) based on reference sequence NM_173957. The size
of the RGN amplicon (100 bp) was verified using an automated electrophoresis
station (Experion Instrument, Bio-Rad), and DNA analysis was performed using
the Experion DNA 1K Analysis Kit (Bio-Rad) [63].
Quantitative expression analyses of RGN
The effect of sex steroid hormones on RGN mRNA expression in the bulbo-
urethral glands, prostate and testis was evaluated through quantitative PCR
(qPCR). To determine the relative amounts of specific RGN transcripts, the cDNA
obtained from retrotranscription was subjected to qPCR [64] using the IQ5
detection system (Bio-Rad) and respective gene primers in an IQ SYBR Green
Supermix (Bio-Rad). The primer sequences for RGN were the same as those used
in the PCR assay. The cyclophilin A (PPIA) was used as a housekeeping gene, as
previously described [57].
The levels of gene expression were calculated using a relative quantification
assay based on the comparative Cq method (DDCq method) [65], previously
verifying that efficiencies of target and housekeeping gene amplification were
similar. Subsequently, the relative abundance of each transcript, normalised to the
endogenous housekeeping gene (PPIA) and relative to the control sample, was
calculated as 22DDCq (fold increase) [66–68].
Western blotting analysis
RGN protein expression was analysed in the tissues of calves and beef cattle using
WB. Total protein was isolated from bovine liver, kidney cortex, adrenal cortex,
adrenal medulla, lung, heart, skeletal muscle, cervical thymus, thoracic thymus,
salivary gland, bulbo-urethral gland, prostate and testis samples using RIPA buffer
(50 mM Tris, pH 8.0, 150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium
deoxycholate, 0.1% SDS and 2 mM EDTA) supplemented with protease inhibitor
cocktail (Sigma). Total protein from perirenal fat and pituitary gland samples was
isolated using TRIzol Reagent (Ambion, Life Technologies) according to the
manufacturer’s protocol. The protein concentration was determined using the
Bio-Rad DC Protein Assay. Twenty micrograms of total protein were resolved
through 12.5% SDS–PAGE. The proteins were blotted onto Trans-Blot
TurboMini Nitrocellulose Transfer membrane (Bio-Rad) using a Trans-Blot
Turbo Blotting System (Bio-Rad). The blotted membranes were blocked with 5%
BSA in TBS-0.1% Tween for 1 h at room temperature, followed by overnight
incubation with an anti-RGN rabbit polyclonal antibody (1:200; Sigma). The
membranes were subsequently incubated with secondary anti-rabbit horseradish
peroxidase (HRP)-conjugated antibody (1:1000), developed using the SuperSignal
West Pico IgG Detection Kit (Thermo Fisher Scientific, Waltham, MA, USA) and
recorded on CL-XPosure X-ray film (Thermo Fisher Scientific).
The effect of sex steroid hormones on RGN protein expression in the bulbo-
urethral glands, prostate and testis of beef cattle was evaluated. In this case, a-
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 5 / 16
tubulin (1:10000, clone B-5-1-2; Sigma) was used as a total protein loading
control.
Immunohistochemistry
The bulbo-urethral glands, prostate and testis of veal calves were examined using
IHC. The immunolocalisation of RGN was performed using an anti-RGN rabbit
polyclonal antibody (Sigma). Briefly, the sections (4 mm) were deparaffinised and
rehydrated. Endogenous peroxidase activity was blocked through incubation in
3% hydrogen peroxide for 15 min. After repeated rinsing with PBS, the sections
were immersed in citrate buffer (10 mM, pH 6.0) and heated in a water bath at
98 C˚ for 40 min for antigen retrieval. The sections were incubated with primary
antibody at a 1:100 dilution for 1 h at room temperature. The immunostaining
was visualised using the EnVision Kit (Dako, Glostrup, Denmark) containing an
HRP-labelled secondary antibody. Diaminobenzidine-hydrogen peroxide solution
(Dako) was used as chromogen and applied for 5 min. The slides were
subsequently rinsed in distilled water to terminate the reaction. After washing, the
slides were counterstained with haematoxylin, dehydrated and mounted with a
cover slip.
Statistical analysis
Statistical analyses were performed using Graph-Pad InStat (vers. 3.05) statistical
software (GraphPad Inc., San Diego, CA, USA). The analysis of RGN gene
expression was performed using one-way analysis of variance (ANOVA), followed
by Dunnett’s post-test. If Bartlett’s test suggested that the difference between the
standard deviations of each group was significant, then the nonparametric
Kruskal-Wallis test with Dunn’s post-test versus the control group was applied.
The Grubbs test was used to reveal potential outliers. A P value of ,0.05 was
considered statistically significant. The data are shown as the mean arbitrary units
(22DCt) ¡ SEM.
Results
RGN expression in various bovine tissues and organs
The PCR analysis, using specific primers, demonstrated RGN mRNA expression
in all tissues examined in both veal calves and beef cattle (Figure 1A and B).
Following PCR, a single band of the correct length (100 bp) was detected. The
presence of RGN protein in the same tissues was further confirmed through WB
analysis (Figure 1C and D), showing a immunoreactive band of 33 kDa.
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Effect of sex steroid hormone on RGN expression in the accessory
sex glands of veal calves
In veal calves, 17b-estradiol administration (group A) decreased RGN expression
in the bulbo-urethral glands (mean of mRNA arbitrary units¡ SEM: 1.56E-03¡
4.03E-04) compared with the control group K1 (6.26E-03¡ 2.30E-03) (P,0.01)
(Figure 2A), in the prostate (1.37E-03 ¡ 9.86E-05) compared with the control
group K1 (3.43E-03¡ 5.51E-04) (P,0.01) (Figure 2B) and in the testis (group A;
3.79E-03 ¡ 5.31E-04) compared with the control group K1 (2.85E-02 ¡ 3.35E-
03) (P,0.01) (Figure 2C). Moreover, RGN expression was down-regulated in the
testis of testosterone-treated veal calves (7.14E-03¡ 1.16E-03) compared with the
control group K1 (2.85E-02 ¡ 3.35E-03) (P,0.01) (Figure 2C).
Immunohistochemical staining demonstrated RGN protein expression in the
bulbo-urethral glands, prostate and testis of veal calves. RGN protein was localised
in the nuclei of glandular cells in the bulbo-urethral glands (Figure 2D, E and F).
The administration of 17b-estradiol (group A) revealed a strong decrease in RGN
protein expression in this organ (Figure 2D) compared with the control group K1
(Figure 2F). Testosterone administration (group B) did not affect RGN protein
expression in the bulbo-urethral glands (Figure 2E). RGN protein was localised to
the cytoplasm of glandular epithelia in the prostate (Figure 2G, H and I). No
staining was observed in the prostate of 17b-estradiol-treated calves (group A)
(Figure 2G). Testosterone administration (group B) did not affect RGN protein
expression in this organ (Figure 2H) compared with the control group K1
Figure 1. RGN expression in different bovine tissues and organs. A virtual gel of the automated capillary electrophoresis of the RGN amplicon (100 bp)
in veal calves (A) and beef cattle (B). Two DNA internal markers (lower, 15 bp; higher, 1500 bp) were added to indicate peak alignments. A representative
western blotting showing RGN protein expression in the different tissues and organs of veal calves (C) and beef cattle (D) using an anti-RGN rabbit
polyclonal antibody (1:200). Lane L: molecular weight marker; 1: liver; 2: kidney cortex; 3: perirenal fat; 4: adrenal cortex; 5: adrenal medulla; 6: lung; 7:
heart; 8: skeletal muscle; 9: cervical thymus; 10: thoracic thymus; 11: pituitary gland; 12: salivary glands; 13: bulbo-urethral glands; 14: prostate; 15: testis.
doi:10.1371/journal.pone.0113950.g001
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(Figure 2I). RGN staining in the testis was predominantly observed in the cytoplasm
of Leydig cells, although the nuclei of some spermatogonia showed weak staining
(Figure 2J, K and L). The immunohistochemical evaluation of the testis of calves
treated with 17b-estradiol (group A) (Figure 2J) revealed a strong decrease in RGN
protein expression compared with the control group K1 (Figure 2L). Only the testis
showed a strong decrease in RGN expression following treatment with testosterone
(group B) (Figure 2K) compared with the control group K1 (Figure 2L).
Effect of sex steroid hormone on RGN expression in the accessory
sex glands of beef cattle
Trenbolone acetate and 17b-estradiol administration (group C) in beef cattle
reduced RGN expression in the prostate (1.41E-03 ¡ 1.32E-04) compared with
the control group K2 (2.936E-03 ¡ 4.34E-04) (P,0.05) (Figure 3B) and in the
testis (4.89E-03 ¡ 9.74E-04) compared with the control group K2 (1.19E-02 ¡
5.68E-04) (P,0.05) (Figure 3C). Moreover, trenbolone acetate treatment (group
D) down-regulated RGN expression in the testis (4.39E-03 ¡ 4.30E-04)
compared with the control group K2 (1.19E-02 ¡ 5.68E-04) (P,0.05)
(Figure 3C). No change in RGN expression was observed in the bulbo-urethral
glands (Figure 3A).
The WB analyses demonstrated RGN expression in the bulbo-urethral glands,
prostate and testis of beef cattle. No effect of sex steroid hormones was observed
in the bulbo-urethral glands (Figure 3D). Treatment with trenbolone acetate and
17b-estradiol (group C) dramatically decreased RGN protein expression
compared with the control group K2 in the testis and particularly in the prostate
(Figure 3D). Moreover, treatment with trenbolone acetate alone (group D) down-
regulated RGN protein expression in the testis compared with the control group
(Figure 3D).
Discussion
Although several studies have investigated RGN function in different species, the
RGN expression in bovine tissues and organs has not been explored. To our
knowledge, this study is the first to report RGN mRNA expression in bovine
organs and tissues other than the liver [69].
WB analysis using an anti-RGN polyclonal antibody showed a reactive
immunoprotein of approximately 33 kDa, corresponding to the predictive size of
RGN. The IHC analyses also confirmed the RGN expression in the accessory sex
glands, where the protein is localised to both the cytoplasm and nuclei of cells.
Indeed, RGN translocates from the cytoplasm to the nucleus where this protein
regulates DNA synthesis and fragmentation [14, 16–18], the expression of
oncogenes, tumour suppressor genes and cell cycle regulators [17–18, 70].
Particularly, this cellular localisation pattern suggests a relevant role in testicular
physiology in both veal calves and beef cattle. RGN is an important regulator of
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
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Figure 2. Effect of sex steroid hormones on RGN expression in the accessory sex glands and testis of veal calves. Effects of 17b-estradiol (group A)
and testosterone (group B) on RGN gene expression compared with the control group K1 in the bulbo-urethral glands (A), prostate (B) and testis (C) of veal
calves. The results are presented as the means ¡ SEM. The y-axes show arbitrary units representing relative mRNA expression levels. A representative
image of the immunohistochemical localisation of RGN protein in paraffin sections of the accessory sex glands and testis of veal calves. RGN staining in the
bulbo-urethral glands (D, E and F), prostate (G, H and I) and testis (J, K and L) of 17b-estradiol- (D, G and J), testosterone- (E, H and K) treated animals and
control (F, I and L) animals. Typical hyperplasia and metaplastic lesions were observed in bulbo-urethral glands (D) and prostate (G) of 17b-estradiol-treated
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
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cellular Ca2+ homeostasis in several tissues. Ca2+ serves important biological
functions, acting as a second messenger in several transduction pathways or
regulating apoptotic cell death, among others [71–72]. A tightly regulated
equilibrium between germ cell apoptosis and proliferation is required for a
successful spermatogenesis [73], as approximately 75% of testicular germ cells
undergo apoptosis [74]. Moreover, the tight control of intracellular Ca2+
homeostasis is critically important in the maintenance of Sertoli cell function
[75–78] and Leydig cell steroidogenesis [79–80]. The histological evaluation of the
testis from veal calves treated with 17b-estradiol or testosterone showed an
interruption of germ cell line development, as previously described [57].
Particularly, testosterone administration caused a severe impairment with the
reduction of germ cells to a layer of spermatogonia, with degenerated dark cells
free in the lumen of seminiferous tubules [57]. This histological effect could be
associated with the observed down-regulation of RGN gene expression in testis.
Indeed, androgens are regulators of testicular cell death and considered as germ
cell survival factors [81–84]. The in silico analysis of the RGN promoter region
revealed different androgen response elements upstream from the transcription
initiation site [28]. Moreover, the RGN-mediated regulation of apoptosis has been
demonstrated in vivo and in vitro [15–19]. RGN inhibits apoptosis through the
up-regulation of Akt-1 and Bcl-2 expression and the down-regulation of caspase-3
expression [85]. The anti-apoptotic effect of RGN has been demonstrated using
knockout mice, whose cells are more prone to apoptosis than their wild-type
counterparts [19, 86]. The reduction of RGN expression via androgen adminis-
tration could inhibit normal spermatogenesis through the stimulation of
abnormal apoptosis and the termination of germ cell line maturation.
RGN expression is modulated through estrogen hormones [23, 28]. The
regulation of RGN expression through estrogens was first described in 1995 in the
liver of rats receiving the subcutaneous administration of 17b-estradiol, resulting
in an increase in RGN mRNA expression [50]. Conversely, the administration of
17b-estradiol reduced RGN expression in the kidney cortex of rats [51]. More
recently, the effect of sex steroid hormones on RGN expression in the breast and
prostate has been demonstrated [23, 28]. The administration of 17b-estradiol to
rats induced the down-regulation of RGN expression in the prostate and
mammary gland [23]. Consistent with these findings, we observed that the
estrogen administration significantly decreased RGN expression not only in the
prostate but also in the testis and bulbo-urethral glands. In particular, the estrogen
administration caused a decrease of RGN expression in bulbo-urethral glands of
veal calves, but not in beef cattle. This marked difference is likely due to
physiological levels of the sex steroid hormones in adult male animals, as
veal calves (asterisk). RGN protein was localised in the nuclei of glandular cells in the bulbo-urethral glands, in the cytoplasm of glandular epithelia in the
prostate and in the cytoplasm of Leydig cells (arrows), although the nuclei of some spermatogonia (arrowheads) showed weak staining.
Immunohistochemistry 400X. *P,0.05, **P,0.01 versus the control group K1.
doi:10.1371/journal.pone.0113950.g002
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previously described for the expression of other estrogen-controlled genes [58].
Moreover, the different treatment schedule could influence the RGN expression.
It has been suggested that RGN has a physiological function in the prostate, as
the expression of this protein is down-regulated in prostate cancer tissues, and
RGN immunoreactivity is correlated with the grade of adenocarcinoma cellular
differentiation [28]. Conversely, RGN expression and the estrogen-mediated
down-regulation of this protein in the bulbo-urethral glands are reported for the
first time in the present study. However, further studies are required to determine
the precise RGN function in these organs. The effect of 17b-estradiol on
morphology of the prostate and bulbo-urethral glands was confirmed by typical
hyperplasia and metaplastic lesions observed in treated veal calves.
The effect of sex steroid hormones on RGN gene expression could play an
important role in the indirect identification of animals illegally treated with
hormones to improve the safety of meat production. This ‘‘omics’’ technology is
based on the concept that after the identification of a specific transcriptional
marker, it can be used to develop a novel screening method for the low-cost
analysis of anabolic treatment in animal production. This approach has led to the
identification of specific biomarkers for use in screening analyses to identify
animals treated with sex steroid hormones. In recent years, for example, PR gene
Figure 3. Effect of sex steroid hormone on RGN expression in the accessory sex glands and testis of beef cattle. Effects of trenbolone acetate and
17b-estradiol (group C) and trenbolone acetate alone (group D) on RGN gene expression compared with the control group K2 in the bulbo-urethral glands
(A), prostate (B) and testis (C) of beef cattle. The results are presented as the means¡ SEM. The y-axes show arbitrary units representing relative mRNA
expression levels. A representative western blot (D) showing RGN protein expression in the bulbo-urethral glands, prostate and testis of beef cattle using an
anti-RGN polyclonal antibody (1:200). a-tubulin was used as loading control. *P,0.05 versus the control group K2.
doi:10.1371/journal.pone.0113950.g003
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expression in the bulbo-urethral glands and prostate has been used as a biomarker
for the illicit estrogen treatment of veal calves and beef cattle [53, 57–58].
Similarly, the variation of oxytocin gene expression in beef cattle muscle is
indicative of estrogen and glucocorticoids illegal treatment [87].
In conclusion, we demonstrated the mRNA and protein expression of RGN in
different bovine organs and tissues, demonstrating a pivotal multi-functional role
for this protein in homeostasis regulation in tissues. In addition, the effect of sex
steroid hormones on RGN expression in target organs, namely the bulbo-urethral
and prostate glands and testis, suggests the potential detection of hormone abuse
in bovine husbandry. Particularly, the specific response in the testis suggests RGN
expression as the first molecular biomarker of illicit androgen administration in
veal calves and beef cattle.
Acknowledgments
The authors would like to thank the Centro di Referenza di Patologia Comparata
‘‘Bruno Maria Zaini’’ (Torino, Italy).
Author Contributions
Conceived and designed the experiments: FTC BB. Performed the experiments:
LSC FTC. Analyzed the data: LSC SD. Contributed reagents/materials/analysis
tools: SD CM. Wrote the paper: LSC FTC BB.
References
1. Yamaguchi M, Yamamoto T (1978) Purification of calcium binding substance from soluble fraction of
normal rat liver. Chem Pharm Bull (Tokyo) 26: 1915–1918.
2. Shimokawa N, Yamaguchi M (1993) Molecular cloning and sequencing of the cDNA coding for a
calcium-binding protein regucalcin from rat liver. FEBS Lett 327: 251–255.
3. Fujita T, Uchida K, Maruyama N (1992) Purification of senescence marker protein-30 (SMP30) and its
androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116: 122–128.
4. Yamaguchi M, Mori S (1989) Activation of hepatic microsomal Ca2+-adenosine triphosphatase by
calcium-binding protein regucalcin. Chem Pharm Bull 37: 1031–1034.
5. Takahashi H, Yamaguchi M (1999) Role of regucalcin as an activator of Ca(2+)-ATPase activity in rat
liver microsomes. J Cell Biochem 74: 663–669.
6. Yamaguchi M, Mori S, Kato S (1988) Calcium-binding protein regucalcin is an activator of (Ca2+-Mg2+)-
adenosine triphosphatase in the plasma membranes of rat liver. Chem Pharm Bull 36: 3532–3539.
7. Takahashi H, Yamaguchi M (1993) Regulatory effect of regucalcin on (Ca(2+)-Mg2+)-ATPase in rat liver
plasma membranes: comparison with the activation by Mn2+ and Co2+. Mol Cell Biochem 124: 169–174.
8. Katsumata T, Yamaguchi M (1998) Inhibitory effect of calcium binding protein regucalcin on protein
kinase activity in the nuclei of regenerating rat liver. J Cell Biochem 71: 569–576.
9. Baba T, Yamaguchi M (2000) Stimulatory effect of regucalcin on proteolytic activity is impaired in the
kidney cortex cytosol of rats with saline ingestion. Mol Cell Biochem 206: 1–6.
10. Tobisawa M, Yamaguchi M (2003) Inhibitory role of regucalcin in the regulation of nitric oxide synthase
activity in rat brain cytosol: involvement of aging. J Neurol Sci 209: 47–54.
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 12 / 16
11. Fukaya Y, Yamaguchi M (2004) Characterization of protein tyrosine phosphatase activity in rat liver
microsomes: suppressive effect of endogenous regucalcin in transgenic rats. Int J Mol Med 14: 427–
432.
12. Yamaguchi M (2005) Role of regucalcin in maintaining cell homeostasis and function. Int J Mol Med 15:
371–389.
13. Yamaguchi M (2012) Role of regucalcin in brain calcium signaling: involvement in aging. Integr Biol
(Camb) 4: 825–837.
14. Misawa H, Inagaki S, Yamaguchi M (2002) Suppression of cell proliferation and deoxyribonucleic acid
synthesis in the cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem 84: 143–
149.
15. Izumi T, Yamaguchi M (2004) Overexpression of regucalcin suppresses cell death and apoptosis in
cloned rat hepatoma H4-II-E cells induced by lipopolysaccharide, PD 98059, dibucaine, or Bay K 8644.
J Cell Biochem 93: 598–608.
16. Tsurusaki Y, Yamaguchi M (2003) Overexpression of regucalcin modulates tumor-related gene
expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem 90: 619–626.
17. Yamaguchi M, Daimon Y (2005) Overexpression of regucalcin suppresses cell proliferation in cloned
rat hepatoma H4-IIE cells: involvement of intracellular signaling factors and cell cycle-related genes.
J Cell Biochem 95: 1169–1177.
18. Nakagawa T, Sawada N, Yamaguchi M (2005) Overexpression of regucalcin suppresses cell
proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med 16:
637–643.
19. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, et al. (2002) Senescence marker protein-30
knockout mouse liver is highly susceptible to tumor necrosis factor-a- and Fas-mediated apoptosis.
Am J Pathol 161: 1273–1281.
20. Matsuyama S, Kitamura T, Enomoto N, Fujita T, Ishigami A, et al. (2004) Senescence marker protein-
30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Biochem Biophys Res Commun
321: 386–390.
21. Jeong DH, Goo MJ, Hong IH, Yang HJ, Ki MR, et al. (2008) Inhibition of radiation-induced apoptosis
via overexpression of SMP30 in Smad3-knockout mice liver. J Radiat Res (Tokyo) 49: 653–660.
22. Ishigami A, Handa S, Maruyama N, Supakar PC (2003) Nuclear localization of senescence marker
protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase. Biosci
Biotechnol Biochem 67: 158–160.
23. Maia CJ, Santos CR, Schmitt F, Socorro S (2008) Regucalcin is expressed in rat mammary gland and
prostate and down-regulated by 17b-estradiol. Mol Cell Biochem 311: 81–86.
24. Arun P, Aleti V, Parikh K, Manne V, Chilukuri N (2011) Senescence Marker Protein 30 (SMP30)
expression in eukaryotic cells: existence of multiple species and membrane localization. PLoS ONE 6:
e16545.
25. Nakashima C, Yamaguchi M (2007) Overexpression of regucalcin suppresses gene expression of
insulin signaling-related proteins in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance.
Int J Mol Med 20:709–716.
26. Nakagawa T, Yamaguchi M (2008) Nuclear localization of regucalcin is enhanced in culture with protein
kinase C activation in cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med
21: 605–610.
27. Yamaguchi M, Weitzmann MN, Baile CA, Murata T (2012) Exogenous regucalcin suppresses
osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture. Integr Biol (Camb) 4:
1215–1222.
28. Maia C, Santos C, Schmitt F, Socorro S (2009) Regucalcin is under-expressed in human breast and
prostate cancers: effect of sex steroid hormones. J Cell Biochem 107: 667–676.
29. Laurentino SS, Correia S, Cavaco JE, Oliveira PF, Rato L, et al. (2011) Regucalcin is broadly
expressed in male reproductive tissues and is a new androgen-target gene in mammalian testis.
Reproduction 142: 447–456.
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 13 / 16
30. Ishii K, Tsubaki T, Fujita K, Ishigami A, Maruyama N, et al. (2005) Immunohistochemical localization
of senescence marker protein-30 (SMP30) in the submandibular gland and ultrastructural changes of the
granular duct cells in SMP30 knockout mice. Histol Histopathol 20: 761–768.
31. Lv S, Wei L, Wang JH, Wang JY, Liu F (2007) Identification of novel molecular candidates for acute liver
failure in plasma of BALB/c murine model. J Proteome Res 6: 2746–2752.
32. Yamaguchi M, Takakura Y, Nakagawa T (2008) Regucalcin increases Ca2+-ATPase activity in the
mitochondria of brain tissues of normal and transgenic rats. J Cell Biochem 104: 795–804.
33. Yamaguchi M, Nakajima R (2002) Role of regucalcin as an activator of sarcoplasmic reticulum Ca2+-
ATPase activity in rat heart muscle. J Cell Biochem 86: 184–193.
34. Akhter T, Sawada N, Yamaguchi M (2006) Regucalcin increases Ca2+-ATPase activity in the heart
mitochondria of normal and regucalcin transgenic rats. M. Int J Mol Med 18: 171–176.
35. Yamaguchi M, Morooka Y, Misawa H, Tsurusaki Y, Nakajima R (2002) Role of endogenous regucalcin
in transgenic rats: suppression of kidney cortex cytosolic protein phosphatase activity and enhancement
of heart muscle microsomal Ca2+-ATPase activity. J Cell Biochem 86: 520–529.
36. Mori T, Ishigami A, Seyama K, Onai R, Kubo S, et al. (2004) Senescence marker protein-30 knockout
mouse as a novel murine model of senile lung. Pathol Int 54: 167–173.
37. Chiusolo A, Defazio R, Casartelli A, Bocchini N, Mongillo M, et al. (2008) Regucalcin down-
regulation in rat kidney tissue after treatment with nephrotoxicants. Toxicol Lett 182: 84–90.
38. Yamaguchi M, Misawa H, Uchiyama S, Morooka Y, Tsurusaki Y (2002b) Role of endogenous
regucalcin in bone metabolism: bone loss is induced in regucalcin transgenic rats. Int J Mol Med 10:
377–383.
39. Yamaguchi M, Sawada N, Uchiyama S, Misawa H, Ma ZJ (2004) Expression of regucalcin in rat bone
marrow cells: involvement of osteoclastic bone resorption in regucalcin transgenic rats. Int J Mol Med
13: 437–443.
40. Lv S, Wang JH, Liu F, Gao Y, Fei R, et al. (2008) Senescence marker protein 30 in acute liver failure:
validation of a mass spectrometry proteomics assay. BMC Gastroenterol 8: 17.
41. Zhou SF, Mo FR, Bin YH, Hou GQ, Xie XX, et al. (2011) Serum immunoreactivity of SMP30 and its
tissues expression in hepatocellular carcinoma. Clin Biochem 44: 331–336.
42. Murata T, Yamaguchi M (1998) Ca2+ administration stimulates the binding of AP-1 factor to the 59-
flanking region of the rat gene for the Ca2+-binding protein regucalcin. Biochem J 329(Pt 1): 157–163.
43. Nejak-Bowen KN, Zeng G, Tan X, Cieply B, Monga SP (2009) b-catenin regulates vitamin C
biosynthesis and cell survival in murine liver. J Biol Chem 284: 28115–28127.
44. Misawa H, Yamaguchi M (2002) Identification of transcription factor in the promoter region of rat
regucalcin gene: binding of nuclear factor I-A1 to TTGGC motif. J Cell Biochem 84: 795–802.
45. Misawa H, Yamaguchi M (2001) Molecular cloning and sequencing of the cDNA coding for a novel
regucalcin gene promoter region-related protein in rat, mouse and human liver. Int J Mol Med 8: 513–
520.
46. Yamaguchi M (2009) Novel protein RGPR-p117: its role as the regucalcin gene transcription factor. Mol
Cell Biochem 327: 53–63.
47. Yamaguchi M, Nakajima M (1999) Involvement of intracellular signaling factors in the serum-enhanced
Ca2+-binding protein regucalcin mRNA expression in the cloned rat hepatoma cells (H4-II-E). J Cell
Biochem 74: 81–89.
48. Sar P, Rath B, Subudhi U, Chainy GB, Supakar PC (2007) Alterations in expression of senescence
marker protein-30 gene by 3,39,5-triiodo-L-thyronine (T3). Mol Cell Biochem 303: 239–242.
49. Yamaguchi M, Otomo Y, Uchiyama S, Nakagawa T (2008) Hormonal regulation of regucalcin mRNA
expression in osteoblastic MC3T3-E1 cells. Int J Mol Med 21: 771–775.
50. Yamaguchi M, Oishi K (1995) 17b-Estradiol stimulates the expression of hepatic calcium-binding
protein regucalcin mRNA in rats. Mol Cell Biochem 143: 137–141.
51. Kurota H, Yamaguchi M (1996) Steroid hormonal regulation of calcium-binding protein regucalcin
mRNA expression in the kidney cortex of rats. Mol Cell Biochem 155: 105–111.
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 14 / 16
52. Carraro L, Ferraresso S, Cardazzo B, Romualdi C, Montesissa C, et al. (2009) Expression profiling of
skeletal muscle in young bulls treated with steroidal growth promoters. Physiol Genomics 38: 138–148.
53. Divari S, Mulasso C, Uslenghi F, Cannizzo FT, Spada F, et al. (2011) Progesterone receptor up-
regulation: a diagnostic tool for the illicit use of oestrogens in adult beef cattle. Food Additives &
Contaminants: Part A 28: 1677–1686.
54. Stella R., Biancotto G., Krogh M., Angeletti R., Pozza G, et al. (2011) Protein expression changes in
skeletal muscle in response to growth promoter abuse in beef cattle. J Proteome Res 10: 2744–2757.
55. Lopparelli R M, Giantin M, Pozza G, Stefani AL, Ravarotto L, et al. (2012) Target gene expression
signatures in neutrophils and lymphocytes from cattle administered with dexamethasone at growth
promoting purposes. Res Vet Sci 93: 226–233.
56. Divari S, Pregel P, Cannizzo FT, Starvaggi Cucuzza L, Brina N, et al. (2013) Oxytocin precursor gene
expression in bovine skeletal muscle is regulated by 17b-oestradiol and dexamethasone. Food Chem
141: 4358–366.
57. De Maria R, Divari S, Spada F, Oggero C, Mulasso C, et al. (2010) Progesterone receptor gene
expression in the accessory sex glands of veal calves. Vet Rec 167: 291–296.
58. Uslenghi F, Divari S, Cannizzo FT, De Maria R, Spada F, et al. (2013) Application of absolute qPCR as
a screening method to detect illicit 17b-oestradiol administration in male cattle. Food Additives &
Contaminants: Part A 30: 253–263.
59. Vanderwal P, Berende IM, Sprietsma JE (1975) Effects of anabolic agents on performance on calves.
J Anim Sci 41: 978–985.
60. Meyer HH (2001) Biochemistry and physiology of anabolic hormones used for improvement of meat
production. APMIS 109: 1–8.
61. Cannizzo FT, Miniscalco B, Riondato F, Bollo E, Barbarino G, et al. (2008) Effects of anabolic and
therapeutic doses of dexamethasone on thymus morphology and apoptosis in veal calves. Vet Rec 163:
448–452.
62. Pegolo S, Cannizzo FT, Biolatti B, Castagnaro M, Bargelloni L (2014) Transcriptomic profiling as a
screening tool to detect trenbolone treatment in beef cattle. Res Vet Sci 96: 472–481.
63. Delibato E, Gattuso A, Minucci A, Auricchio B, De Medici D, et al. (2009) PCR Experion automated
electrophoresis system to detect Listeria monocytogenes in foods. J Sep Sci 32: 3817–3821.
64. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jona`k J, et al. (2006) The real-time polymerase
chain reaction. Mol Aspects Med 27: 95–125.
65. Bustin SA, Benes V, Garson JA, Hellemans J, Hugget J, et al. (2009). The MIQE guidelines:
Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622.
66. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative
PCR and the 22DDCt method. Methods 25: 402–408.
67. Pfaffl MW (2004) Quantification strategies in real-time PCR. In, Bustin SA, editor. A-Z of quantitative
PCR. International University Line (IUL), La Jolla, CA, USA: E-Publishing Inc. pp. 87–112.
68. Wong ML, Medrano JF (2005) Real-time PCR for mRNA quantitation. BioTechniques 39: 75–85.
69. Shimokawa N, Isogai M, Yamaguchi M (1995) Specific species and tissue differences for the gene
expression of calcium-binding protein regucalcin. Mol Cell Biochem 143: 67–71.
70. Tsurusaki Y, Yamaguchi M (2004) Role of regucalcin in liver nuclear function: binding of regucalcin to
nuclear protein or DNA and modulation of tumor-related gene expression. Int J Mol Med 14: 277–281.
71. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and
remodelling. Nat Rev Mol Cell Biol 4: 517–529.
72. Clapham DE (2007) Calcium signaling. Cell 131: 1047–1058.
73. Print CG, Loveland KL (2000) Germ cell suicide: new insights into apoptosis during spermatogenesis.
Bioessays 22: 423–430.
74. Giampietri C, Petrungaro S, Coluccia P, D’Alessio A, Starace D, et al. (2005) Germ cell apoptosis
control during spermatogenesis. Contraception 72: 298–302.
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 15 / 16
75. Spruill WA, Zysk JR, Tres LL, Kierszenbaum AL (1983) Calcium/calmodulin-dependent
phosphorylation of vimentin in rat sertoli cells. Proc Natl Acad Sci USA 80: 760–764.
76. Franchi E, Camatini M (1985) Evidence that a Ca2+ chelator and a calmodulin blocker interfere with the
structure of inter-Sertoli junctions. Tissue Cell 17: 13–25.
77. Grima J, Wong CC, Zhu LJ, Zong SD, Cheng CY (1998) Testin secreted by Sertoli cells is associated
with the cell surface, and its expression correlates with the disruption of Sertoli-germ cell junctions but
not the inter-Sertoli tight junction. J Biol Chem 273: 21040–21053.
78. Gorczynska-Fja¨lling E (2004) The role of calcium in signal transduction processes in Sertoli cells.
Reprod Biol 4: 219–241.
79. Manna PR, Pakarinen P, El-Hefnawy T, Huhtaniemi IT (1999) Functional assessment of the calcium
messenger system in cultured mouse Leydig tumor cells: regulation of human chorionic gonadotropin-
induced expression of the steroidogenic acute regulatory protein. Endocrinology 140: 1739–1751.
80. Pandey AK, Li W, Yin X, Stocco DM, Grammas P, et al. (2010) Blocking L-type calcium channels
reduced the threshold of cAMP-induced steroidogenic acute regulatory gene expression in MA-10
mouse Leydig cells. J Endocrinol 204: 67–74.
81. Henriksen K, Hakovirta H, Parvinen M (1995) Testosterone inhibits and induces apoptosis in rat
seminiferous tubules in a stage-specific manner: in situ quantification in squash preparations after
administration of ethane dimethane sulfonate. Endocrinology 136: 3285–3291.
82. Erkkila K, Henriksen K, Hirvonen V, Rannikko S, Salo J, et al. (1997) Testosterone regulates
apoptosis in adult human seminiferous tubules in vitro. J Clin Endocrinol Metab 82: 2314–2321.
83. Kim SK, Yoon YD, Park YS, Seo JT, Kim JH (2007) Involvement of the Fas-Fas ligand system and
active caspase-3 in abnormal apoptosis in human testes with maturation arrest and Sertoli cell-only
syndrome. Fertil Steril 87: 547–553.
84. Bakalska M, Atanassova N, Koeva Y, Nikolov B, Davidoff M (2004) Induction of male germ cell
apoptosis by testosterone withdrawal after ethane dimethanesulfonate treatment in adult rats. Endocr
Regul 38: 103–110.
85. Nakagawa T, Yamaguchi M (2005) Overexpression of regucalcin suppresses apoptotic cell death in
cloned normal rat kidney proximal tubular epithelial NRK52E cells: change in apoptosis-related gene
expression. J Cell Biochem 96: 1274–1285.
86. Maruyama N, Ishigami A, Kuramoto M, Handa S, Kubo S, et al. (2004) Senescence marker protein-
30 knockout mouse as an aging model. Ann N Y Acad Sci 1019: 383–387.
87. Divari S, Pregel P, Cannizzo FT, Starvaggi Cucuzza L, N. Brina N, et al. (2013)Oxytocin precursor
gene expression in bovine skeletal muscle is regulated by 17b-oestradiol and dexamethasone. Food
Chem 141: 4358–4366.
Regucalcin a Novel Biomarker of Androgen Illicit Treatment in Cattle
PLOS ONE | DOI:10.1371/journal.pone.0113950 November 21, 2014 16 / 16
